Interestingly, circPTK2 can bind to Ser38, Ser55, and Ser82 sites of vimentin and induce EMT in vitro and in vivo and targeting of circPTK2 using shRNA significantly suppressed tumor metastasis in a xenograft mouse model of CRC [161]. Here, VIM is linked to neoplasm.